MedPath

TRIM: Danish Form and Dose Study on Vitamin B12

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT02832726
Lead Sponsor
University of Aarhus
Brief Summary

The study investigates the absorption of different doses of hydroxocobalamin and cyanocobalamin in a vitamin B12-replete Danish population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • At least 18 years old
Exclusion Criteria
  • Use of vitamin pills with vitamin B12 within the last two weeks of the study
  • Treatment with vitamin B12 injections within the last year
  • Known chronic systemic disease
  • Not able to give informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Vitamin B12 absorption (increase in holotranscobalamin)3 days
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.